FDA lifts hold on Biomea’s diabetes trials

The FDA lifted a clinical hold on two trials testing Biomea Fusion’s diabetes treatment.

The news, announced Thursday, sent the company …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

UCD leads major EU project on extracellular vesicles for biomedical research

A major EU project coordinated from UCD is set to push the frontiers of biomedical research by exploring the transformative potential of extracellular vesicles (EVs).

November 7, 2024

Why doesn’t everyone lose weight on Ozempic-type drugs? Researchers look for genetic clues

DALLAS — Treatments like Ozempic, Wegovy, and Mounjaro have been hailed for showing 15% to over 20% weight loss in trials, but those are just

October 18, 2023

Dr. Alan K. Davis | Director, Center for Psychedelic Drug Research and Education | Psychedelic Finance

Dr. Alan K. Davis is a Clinical Psychologist and the Director of the Center for Psychedelic Drug Research and Education in the College of Social

October 18, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.